Clarify Health

APRIL 18, 2024

As both government and commercial payers direct a greater share of volume to out-patient facilities and patient demand for same-day service increases, opportunity and competition in the ambulatory surgical center (ASC) space are increasing. Is there an ASC in your market you should merge with or acquire?

Marketing 52

Marketing Competition Physicians Management 52

pharmaphorum

JULY 22, 2022

A just-published report on the UK’s life sciences sector “ought to ring alarm bells across government,” according to the Association of the British Pharmaceutical Industry (SBPI). The Life Sciences Competitiveness Indicators report shows that spending on life sciences R&D was £2.7 Draft finance bill.

Government 52

Government Medicine Recruitment Competition 52

pharmaphorum

JANUARY 16, 2023

Since 2014, the repayment percentage detailed in the VPAS and predecessor the PPRS averaged at around 7%, but skyrocketed to 19% in 2022 ahead of a government-agreed cap at 15%, and rose again to 26.5% The ABPI said that exposes “the depth of feeling that the current voluntary scheme is damaging the UK life sciences industry.”

Government 67

Government Medicine Consulting Management 67

Rep-Lite

MAY 10, 2024

From groundbreaking advancements in technology to a growing emphasis on patient-centricity, the industry is constantly evolving. Regulatory Changes and Compliance Challenges Navigating the intricacies of healthcare sales involves staying attuned to the ever-evolving regulatory framework that governs the industry.

Medical sales 52

Medical sales Sales Medical Medical sales reps 52

Clarify Health

SEPTEMBER 29, 2023

Healthcare Centers of Excellence are recognized for their commitment to quality, expertise, and the pursuit of the best possible outcomes for patients. They often play a critical role in advancing medical knowledge and improving patient care in specialized areas of healthcare. Feeling inspired?

Networking 52

Networking Healthcare Healthcare Competition 52

Pharmaceutical Technology

OCTOBER 17, 2022

The UK Government has announced funding worth more than $894.6m (£800m) to back research into ground-breaking, experimental therapies and progress the response of the country to patient safety challenges. These research centres comprise a new facility in Exeter. The post UK to offer $894.6m

Safety 52

Safety Government Competition Patients 52

pharmaphorum

OCTOBER 20, 2022

Together, these groups compile vast amounts of data, including rich information on patient populations, target customers, and the competitive landscape. Historically, competitive and market analysis data has been stored in spreadsheets. Truly understanding the competitive landscape and market environment.

Competition 94

Competition Marketing Pharma Biopharma 94

PM360

APRIL 7, 2023

What other policy issues or potential changes by the government should companies be aware of? However, we expect drugs without strong therapeutic alternatives to have an advantage in negotiations, while drugs in highly competitive classes will be negotiating from a weaker position. price of its most prescribed insulin brand.

Manufacturing 97

Manufacturing Insurance Government Marketing 97

Pharmaceutical Technology

OCTOBER 5, 2022

Bringing an end to a 13-year deliberation on a whistleblower lawsuit, Biogen recently agreed to pay a $900 million settlement , amidst increased government alertness on pharmaceutical fraud. However, new MS drugs like Novartis ’ Gilenya, were going to soon enter the market and increase competition within the MS therapeutic landscape.

Government 59

Government Specialization Physicians Education 59

World of DTC Marketing

MAY 26, 2021

Here is the executive summary of the Government’s report on AbbVie. Today, Imbruvica is priced at $181,529 per year for a patient taking three pills per day, compared to $99,776 per year at launch. AbbVie has obtained or applied for over 250 patents on Humira to block competition from lower-priced biosimilars.

Competition 180

Competition Marketing Government Patients 180

PM360

JUNE 26, 2023

This can be especially important in the current global economic climate, where competition for market share is fierce, and access to new customers is critical for growth. This includes ensuring access and affordability of their products, which can positively impact their environmental social governance (ESG) score and reputation.

Medicine 98

Medicine Marketing Pharma Manufacturing 98

Pharmaceutical Technology

JULY 21, 2022

As part of ESG (Environmental, Social, and Governance), the social good delivered by robust healthcare systems are at the core of healthy populations. The Covid-19 pandemic has demonstrated how vital patient access to quality and affordable healthcare is for patients all over the world.

Government 52

Government Healthcare Healthcare Pharma 52

Spotio

FEBRUARY 21, 2023

The goals are to increase quality, decrease costs and turn health care into a competitive marketplace. It’s intended to give patients cost and quality information on drugs and hospitals. For the first time, patients will also be informed consumers. The new goal is to meet patients’ needs at home.

Medical sales 52

Medical sales Medical Sales Physicians 52

pharmaphorum

NOVEMBER 17, 2022

Predictable for government. The 2019 VPAS deal was struck as a negotiation between DHSC, NHS England, the devolved nations, as well as others on the side of the government and industry body, the ABPI. Patients, too, are calling for a role this time around. More transparency needed. Individual companies are lobbying, too.

Government 98

Government Sales Medicine Consulting 98

MedReps

SEPTEMBER 19, 2022

Often we’re lucky if we even get to see our physicians, let alone overcome their objections regarding insurance coverage and competitive claims. Another enduring wall for medical sales reps to climb is making their products affordable to patients. Insurance Coverage. Physician Apathy. Competitors and Generic Medications.

Medical sales 66

Medical sales Medical sales reps Medical Sales 66

Pharmaceutical Technology

NOVEMBER 23, 2022

One of the primary focus areas includes the continued commercialisation of cutting-edge cell and gene therapies, which involve the modification of cells from patients or donors to produce highly personalised therapies and regenerative medicines. In Canada, the government is working to boost domestic biomanufacturing capacity.

Marketing 52

Marketing Manufacturing Transportation Government 52

PM360

NOVEMBER 12, 2023

This should, at least in theory, make them an appealing target for biopharma companies looking to expand beyond the hugely competitive markets of the U.S., For biopharma companies, both these areas potentially represent an opportunity for significant patient return on investment. Europe, and parts of Asia.

Marketing 59

Marketing Biopharma Government Pharma 59

PharmaKinnex

AUGUST 23, 2022

From new legislation to functional shifts in marketing and advertising, the pharma industry works hard every day to keep up with new regulatory requirements and the constantly evolving expectations of prescribers and patients. – Increased Caution From Patients & Prescribers. – New & Updated Legislation.

Pharma 52

Pharma Sales Sales Strategy Marketing 52

pharmaphorum

JANUARY 19, 2023

It was a unique event, at which leaders from across the pharmaceutical pipeline addressed the needs of the industry, shared their own insights, and tackled debates on the crucial topics that influence the future of patient outcomes. When Milburn and Blair introduced competition in 2004-2008 it did start to make a difference.”

Pharma 79

Pharma Competition Healthcare Healthcare 79

Clarify Health

JUNE 8, 2023

Patient outcomes, referral patterns, claims — the spreadsheets are nearly endless. A changing industry demands a data-driven response When it comes to choosing when, where, and how to receive care, today’s patients have more choices than ever. Start by analyzing available data about current patients and the surrounding community.

Healthcare 52

Healthcare Healthcare Physicians Patients 52

Clarify Health

SEPTEMBER 7, 2022

There is heightened competition from non-traditional actors, like Amazon (with its acquisition of One Medical ), a continuous push from government and commercial payers to accept greater financial risk, and an increase in consumer-directed care decisions. Strengthening physician alignment.

Networking 52

Networking Physicians Competition Marketing 52

Clarify Health

SEPTEMBER 7, 2022

There is heightened competition from non-traditional actors, like Amazon (with its acquisition of One Medical ), a continuous push from government and commercial payers to accept greater financial risk, and an increase in consumer-directed care decisions.

Networking 52

Networking Physicians Competition Marketing 52

pharmaphorum

JULY 15, 2022

The case hinges around the concept of “ skinny labelling ” which was introduced to stop drugmakers extending the exclusivity period for their branded medicines – through a stream of new indications or patient populations – that can be protected with so-called “use” patents. The substance patent expired in 2007.

Prescription 52

Prescription Doctors Government Marketing 52

Pharmaceutical Technology

DECEMBER 22, 2022

Theft, fraudulent prescriptions and unsanctioned distribution by patients and medical practitioners are the most common ways in which legal fentanyl products are illegally secured. Fentanyl was first synthesised in 1959 and introduced to markets in the 1960s as a pain relief drug. A dangerous future.

Safety 105

Safety Manufacturing Distribution Prescription 105

Medico Reach

DECEMBER 2, 2022

Besides, it has clients and partners covering various sectors, including pharmaceutical companies, biotech firms, medical device manufacturers, and government or academic organizations. Moreover, its services are spread through care organizations, hospitals, government agencies, pharmaceutical companies, and physicians.

Consulting 98

Consulting Specialization Medicine Medical 98

pharmaphorum

NOVEMBER 10, 2022

Having noted that by 2035 it is predicted that there will be a 24% increase in cancer diagnoses, Arlukwiez, BECA’s chair, stressed within his recorded apology message that the patient is the guiding principle and that there must be equality of treatment across the EU. Excellence in cancer care is not just survivorship, but patient outcome.

Electronics 85

Electronics Government Patients Pharma 85

Pharmaceutical Technology

MARCH 27, 2023

Resilience is honoured to partner with the DFC, DoD, and the US government to ensure this country can maintain its innovative, competitive edge in biotechnology and biomanufacturing, while generating significant benefits to the health, security and quality of American lives and those around the world.”

Manufacturing 52

Manufacturing Government Competition Networking 52

Clarify Health

DECEMBER 21, 2021

No surprise billing: A breakdown of the key requirements and deadlines in the No Surprises Act The No Surprises Act aims to protect patients from receiving “surprise” (or unexpected) medical bills from a healthcare provider or facility after inadvertently receiving care from an out-of-network provider.

Healthcare 52

Healthcare Healthcare Networking Healthcare Provider 52

Scott’s Directories

OCTOBER 19, 2022

One of the most competitive industries in the United States is healthcare. government reveal that in 2019, spending on healthcare increased to about $3.8 Digital Research Most healthcare providers, marketers, and patients turn to the internet for the information they need. Statistics from the U.S.

Healthcare 52

Healthcare Healthcare Marketing Media 52

pharmaphorum

JULY 21, 2016

New measures proposed by the Government will impact community pharmacies across the UK; the biggest change of this nature in decades. UK pharmacies already support more inhabitants per pharmacy than other major European markets; how will this funding change impact how patients are cared for in the community?

Government 40

Government Competition Marketing Patients 40

Contrarian Sales Techniques

FEBRUARY 21, 2023

While they may not be directly involved in patient care, they play an important role in promoting and educating healthcare providers about the latest treatments and technologies. This can have a significant impact on patient outcomes and overall public health.

Pharma sales reps 40

Pharma sales reps Sales Pharma Healthcare Provider 40

pharmaphorum

JANUARY 27, 2023

An additional note of optimism is that UK biotechs achieved pivotal milestones in their development, with Verona Pharma reporting a successful phase 3 trial for Ensifentrine, the first novel compound in over 10 years to address the ongoing needs of more than 380 million patients worldwide suffering from Chronic Obstructive Pulmonary Disease (COPD).

Pharma 52

Pharma Manufacturing Biopharma Medicine 52

pharmaphorum

NOVEMBER 25, 2022

Alberto Chiesi also remarked that the industry is grappling with growing global competition, in which Europe is losing ground in R&D: 48% of new products globally are developed in the United States, compared with 25% in Europe. The situation was reversed only 25 years ago. And so, pharmaceutical spending is an investment, he said.

Pharmaceutical 96

Pharmaceutical Manufacturing Medicine Competition 96

European Pharmaceutical Review

JUNE 24, 2022

The review was impacted by Brexit and the COVID-19 pandemic, which compounded existing issues surrounding high drug pricing and patient access that had been brewing since 2016 and highlighted several shortcomings in the EU’s pharmaceutical system. Key areas of potential legislative change. Reducing market exclusivity. Conclusions.

Pharmaceutical 98

Pharmaceutical Medicine Marketing Competition 98

Nixon Gwilt Law

SEPTEMBER 7, 2023

Pediatric healthcare innovation companies—especially those in AR/VR/XR, Digital Therapeutics (“DTx”), Remote Monitoring, Virtual Care Management, Telehealth, and Telebehavioral health—need a deep understanding of the laws and regulations that govern this special market. Want to tackle these legal hurdles with confidence?

Food and Drug Administration 52

Food and Drug Administration Education Insurance Healthcare 52

pharmaphorum

JANUARY 26, 2023

The £340 million fund will provide non-cancer patients access to cutting-edge treatments that still have uncertainties at the time of launch and promotes the UK as an attractive launch destination. There are small patient numbers, uncertainties in the cost-effectiveness model and clinical pathway and often a lack of comparative data.

Medicine 57

Medicine Patients Management Marketing 57

Clarify Health

MARCH 17, 2023

This black box prevents commercial payers, employers, and patients from selecting more affordable healthcare providers and allows some hospitals to charge commercial payers service rates far above those set by public payers such as Medicare. This has led to a wider variation in hospital reporting format and quality.

Healthcare 52

Healthcare Healthcare Competition Networking 52